BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Murray PHN - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://murrayphn.org.au
X-WR-CALDESC:Events for Murray PHN
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20261119T180000
DTEND;TZID=Australia/Melbourne:20261119T190000
DTSTAMP:20261030T035852Z
CREATED:20261030T035852Z
LAST-MODIFIED:20261030T035852Z
UID:10003352-1795111200-1795114800@murrayphn.org.au
SUMMARY:What’s next for COPD? Understanding the role of biologics | Online
DESCRIPTION:Hosted by the Lung Foundation Australia \nMany people living with COPD continue to experience significant symptoms and exacerbations despite optimised pharmacological and non-pharmacological management. For these patients\, emerging biologic therapies may offer a new approach to improving symptoms\, reducing exacerbations and supporting quality of life. Understanding when biologics may be appropriate starts with ensuring COPD has been accurately diagnosed and that standard management has been optimised. But how do you identify patients who may benefit from biologic therapy\, and when should they be referred for specialist assessment? \nLearning outcomes: \n\nDescribe the key components of optimised COPD management\, including pharmacological and non-pharmacological management\, inhaler technique and management of comorbidities.\nOutline the role of biologic therapies in COPD\, including their rationale\, mechanisms of action and the evidence supporting their use.\nIdentify patients who may be eligible for biologic therapy and describe appropriate referral pathways and considerations for specialist assessment.\n\nAudience: General practitioners \nClick here to learn more and register.
URL:https://murrayphn.org.au/event/whats-next-for-copd-understanding-the-role-of-biologics-online/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://murrayphn.org.au/wp-content/uploads/2024/05/event-external.jpg
ORGANIZER;CN="Lung Foundation Australia":MAILTO:enquiries@lungfoundation.com.au
END:VEVENT
END:VCALENDAR